440 related articles for article (PubMed ID: 17136757)
1. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion.
Ong CT; Khoo YT; Tan EK; Mukhopadhyay A; Do DV; Han HC; Lim IJ; Phan TT
J Pathol; 2007 Jan; 211(1):95-108. PubMed ID: 17136757
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
3. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices.
Mukhopadhyay A; Tan EK; Khoo YT; Chan SY; Lim IJ; Phan TT
Br J Dermatol; 2005 Apr; 152(4):639-45. PubMed ID: 15840092
[TBL] [Abstract][Full Text] [Related]
4. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
[TBL] [Abstract][Full Text] [Related]
6. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro.
Riedel K; Riedel F; Goessler UR; Germann G; Sauerbier M
Arch Med Res; 2007 Jan; 38(1):45-51. PubMed ID: 17174722
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis.
Khoo YT; Ong CT; Mukhopadhyay A; Han HC; Do DV; Lim IJ; Phan TT
J Cell Physiol; 2006 Aug; 208(2):336-43. PubMed ID: 16705627
[TBL] [Abstract][Full Text] [Related]
8. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
[TBL] [Abstract][Full Text] [Related]
9. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
[TBL] [Abstract][Full Text] [Related]
11. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts.
Florin L; Maas-Szabowski N; Werner S; Szabowski A; Angel P
J Cell Sci; 2005 May; 118(Pt 9):1981-9. PubMed ID: 15840658
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.
Riedel K; Koellensperger E; Ryssel H; Riedel F; Goessler UR; Germann G; Kremer T
Int J Mol Med; 2008 Oct; 22(4):473-80. PubMed ID: 18813854
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
14. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation.
Rossiter H; Barresi C; Pammer J; Rendl M; Haigh J; Wagner EF; Tschachler E
Cancer Res; 2004 May; 64(10):3508-16. PubMed ID: 15150105
[TBL] [Abstract][Full Text] [Related]
15. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
16. VEGF is upregulated in a neuroblastoma and hepatocyte coculture model.
Beierle EA; Strande LF; Berger AC; Chen MK
J Surg Res; 2001 May; 97(1):34-40. PubMed ID: 11319877
[TBL] [Abstract][Full Text] [Related]
17. A simple in vitro model for investigating epithelial/mesenchymal interactions: keratinocyte inhibition of fibroblast proliferation and fibronectin synthesis.
Harrison CA; Dalley AJ; Mac Neil S
Wound Repair Regen; 2005; 13(6):543-50. PubMed ID: 16283869
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
19. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor.
Koshida Y; Kuranami M; Watanabe M
J Surg Res; 2006 Aug; 134(2):270-7. PubMed ID: 16600304
[TBL] [Abstract][Full Text] [Related]
20. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
Nakamura K; Sata M; Iwata H; Sakai Y; Hirata Y; Kugiyama K; Nagai R
Clin Sci (Lond); 2007 Jun; 112(12):607-16. PubMed ID: 17263691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
